Robotic Natural Orifice Specimen Extraction Surgery Compared to Robotic Assisted Surgery for Median Rectal Cancer

Launched by NANCHANG UNIVERSITY · Jun 11, 2024

Keywords

ClinConnect Summary

A major concern to the safety of the public's health is the prevalence of colorectal cancer, which is the third most prevalent cancer and has a very high fatality rate. There are multiple treatments for rectal cancer, and surgery remains one of the most important ways. Laparoscopic surgery as a minimally invasive technique for the treatment of colorectal has been confirmed by many studies to ensure its safety and reliability. Laparoscopic surgery has also been widely used in clinical. So far, NOSES, as an emerging minimally invasive technology, has caused heated discussions in the minimally...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. The age is more than 18 years old and less than or equal to 85 years old
• • 2. Eastern Cooperative Oncology Group score ≤2
• • 3. Preoperative pathological diagnosis of rectal adenocarcinoma
• • 4. cT1-3NxM0 median rectal cancer defined by preoperative contrast-enhanced MRI
• • 5. The maximum diameter of tumor ≤5cm on preoperative enhanced MRI
• • 6. The body can tolerate the operation and sign the informed consent
• Exclusion Criteria:
• • 1. multiple primary colorectal cancer
• • 2. recurrent rectal cancer
• • 3. preoperative neoadjuvant chemoradiotherapy
• • 4. complicated with intestinal obstruction or intestinal bleeding requiring emergency surgery
• • 5. previous anal surgery history
• • 6. BMI≥30kg/m2
• • 7. severe mental illness